Design of Peptidomimetic Based DPP-IV Inhibitors, Devoid of CYP Liabilities

Author(s): Pradip Jadav, Rajesh Bahekar, Shailesh R. Shah, Dipam Patel, Amit Joharapurkar, Kiran Shah, Shruti Bhardwaj, Kishan Patel, Kaushil Patel, Rajendra Chopade, Mubeen Shaikh, Kalapatapu V.V.M. Sairam, Mukul Jain

Journal Name: Letters in Drug Design & Discovery

Volume 9 , Issue 9 , 2012

Become EABM
Become Reviewer


A peptidomimetic based cyanopyrrolidine derivatives are reported as potent and selective DPP-IV inhibitors. Some of the test compounds (10l and 10m) showed excellent potency and selectivity towards DPP-IV over various serine proteases, without CYP inhibition.

Keywords: CYP, cyanopyrrolidine, DPP-IV inhibitors, Selectivity, Peptidomimetic

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [867 - 873]
Pages: 7
DOI: 10.2174/157018012803307932
Price: $65

Article Metrics

PDF: 7